{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T20:36:56Z","timestamp":1781987816189,"version":"3.54.5"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,5,14]],"date-time":"2018-05-14T00:00:00Z","timestamp":1526256000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["403293\/2005-7"],"award-info":[{"award-number":["403293\/2005-7"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.00915","type":"journal-article","created":{"date-parts":[[2018,5,14]],"date-time":"2018-05-14T04:14:12Z","timestamp":1526271252000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["Mycobacterium leprae-Specific Antibodies in Multibacillary Leprosy Patients Decrease During and After Treatment With Either the Regular 12 Doses Multidrug Therapy (MDT) or the Uniform 6 Doses MDT"],"prefix":"10.3389","volume":"9","author":[{"given":"Emerith M.","family":"Hungria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"B\u00fchrer-S\u00e9kula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regiane M.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00facio C.","family":"Aderaldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Araci A.","family":"Pontes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossilene","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heitor S. de","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria L. F.","family":"Penna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerson O.","family":"Penna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariane M. A.","family":"Stefani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,5,14]]},"reference":[{"key":"B1","first-page":"255","article-title":"Classification of leprosy according to immunity. A five-group system","volume":"34","author":"Ridley","year":"1966","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1128\/CMR.19.2.338-381.2006","article-title":"The continuing challenges of leprosy","volume":"19","author":"Scollard","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"B3","first-page":"476","article-title":"Use of synthetic glycoconjugates containing the Mycobacterium leprae specific and immunodominant epitope of phenolic glycolipid I in the serology of leprosy","volume":"64","author":"Brett","year":"1986","journal-title":"Clin Exp Immunol"},{"key":"B4","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1128\/JCM.28.3.525-529.1990","article-title":"Novel gelatin particle agglutination test for serodiagnosis of leprosy in the field","volume":"28","author":"Izumi","year":"1990","journal-title":"J Clin Microbiol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/j.1574-695X.1998.tb01166.x","article-title":"The use of whole blood in a dipstick assay for detection of antibodies to Mycobacterium leprae: a field evaluation","volume":"21","author":"Buhrer-Sekula","year":"1998","journal-title":"FEMS Immunol Med Microbiol"},{"key":"B6","first-page":"456","article-title":"Use of ML dipstick as a tool to classify leprosy patients","volume":"68","author":"Buhrer-Sekula","year":"2000","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1046\/j.1365-3156.2001.00704.x","article-title":"Dipstick assay to identify leprosy patients who have an increased risk of relapse","volume":"6","author":"Buhrer-Sekula","year":"2001","journal-title":"Trop Med Int Health"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1128\/JCM.41.5.1991-1995.2003","article-title":"Simple and fast lateral flow test for classification of leprosy patients and identification of contacts with high risk of developing leprosy","volume":"41","author":"Buhrer-Sekula","year":"2003","journal-title":"J Clin Microbiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.actatropica.2009.04.009","article-title":"The additional benefit of the ML flow test to classify leprosy patients","volume":"111","author":"Buhrer-Sekula","year":"2009","journal-title":"Acta Trop"},{"key":"B10","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.6348948","article-title":"A serological test for leprosy with a glycolipidspecific for Mycobacterium leprae","volume":"221","author":"Young","year":"1983","journal-title":"Science"},{"key":"B11","doi-asserted-by":"crossref","first-page":"70","DOI":"10.47276\/lr.78.1.70","article-title":"The ML flow test as a point of care test for leprosy control programmes: potential effects on classification of leprosy patients","volume":"78","author":"Buhrer-Sekula","year":"2007","journal-title":"Lepr Rev"},{"key":"B12","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/31159","article-title":"Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence","volume":"393","author":"Cole","year":"1998","journal-title":"Nature"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/35059006","article-title":"Massive gene decay in the leprosy bacillus","volume":"409","author":"Cole","year":"2001","journal-title":"Nature"},{"key":"B14","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1128\/CVI.13.3.333-340.2006","article-title":"ML0405 and ML2331 are antigens of Mycobacterium leprae with potential for diagnosis of leprosy","volume":"13","author":"Reece","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1128\/CVI.00299-07","article-title":"Use of protein antigens for early serological diagnosis of leprosy","volume":"14","author":"Duthie","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1128\/CVI.00234-08","article-title":"Antigen-specific T-cell responses of leprosy patients","volume":"15","author":"Duthie","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1471-2334-11-26","article-title":"Immunologically reactive M. leprae antigens with relevance to diagnosis and vaccine development","volume":"11","author":"Sampaio","year":"2011","journal-title":"BMC Infect Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1590\/S0074-02762012000900017","article-title":"Seroreactivity to new Mycobacterium leprae protein antigens in different leprosy-endemic regions in Brazil","volume":"107","author":"Hungria","year":"2012","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"B19","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1186\/1471-2334-13-497","article-title":"Development of a quantitative rapid diagnostic test for multibacillary leprosy using smart phone technology","volume":"13","author":"Cardoso","year":"2013","journal-title":"BMC Infect Dis"},{"key":"B20","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1128\/JCM.02085-13","article-title":"Rapid quantitative serological test for detection of infection with Mycobacterium leprae, the causative agent of leprosy","volume":"52","author":"Duthie","year":"2014","journal-title":"J Clin Microbiol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.diagmicrobio.2014.02.006","article-title":"A rapid ELISA for the diagnosis of MB leprosy based on complementary detection of antibodies against a novel protein-glycolipid conjugate","volume":"79","author":"Duthie","year":"2014","journal-title":"Diagn Microbiol Infect Dis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e0004934","DOI":"10.1371\/journal.pntd.0004934","article-title":"Identifying leprosy and those at risk of developing leprosy by detection of antibodies against LID-1 and LID-NDO","volume":"10","author":"Amorim","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1590\/0037-8682-0226-2015S0037-86822016000200158","article-title":"Integrative literature review of the reported uses of serological tests in leprosy management","volume":"49","author":"Fabri","year":"2016","journal-title":"Rev Soc Bras Med Trop"},{"key":"B24","volume-title":"1. Leprosy \u2013 Epidemiology. 2. Leprosy \u2013 Prevention and Control. 3. Leprosy \u2013 Therapy","year":"2010"},{"key":"B25","first-page":"62","article-title":"Progress in the serology of leprosy at the University of Hawaii","volume":"47","author":"Douglas","year":"1988","journal-title":"Hawaii Med J"},{"key":"B26","first-page":"735","article-title":"PGL-I antigen and antibody detection in leprosy patients: evolution under chemotherapy","volume":"57","author":"Chanteau","year":"1989","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"B27","first-page":"744","article-title":"Serum antibodies to defined carbohydrate antigens during the course of treated leprosy","volume":"57","author":"Gelber","year":"1989","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"B28","first-page":"109","article-title":"Employment status of leprosy patients with deformities in a suburban slum","volume":"62","author":"Chaturvedi","year":"1990","journal-title":"Indian J Lepr"},{"key":"B29","first-page":"35","article-title":"Serological monitoring of the response to chemotherapy in leprosy patients","volume":"61","author":"Roche","year":"1993","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"B30","first-page":"497","article-title":"Immunological reactions to mycobacterial proteins in the spectrum of leprosy","volume":"65","author":"Rada","year":"1997","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1128\/CDLI.8.1.138-142.2001","article-title":"Detection of phenolic glycolipid I of Mycobacterium leprae in sera from leprosy patients before and after start of multidrug therapy","volume":"8","author":"Cho","year":"2001","journal-title":"Clin Vaccine Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1007\/s10096-011-1221-2","article-title":"Specific IgG antibody responses may be used to monitor leprosy treatment efficacy and as recurrence prognostic markers","volume":"30","author":"Duthie","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"B33","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1590\/S0074-02762012000900014","article-title":"Identification of serological biomarkers of infection, disease progression and treatment efficacy for leprosy","volume":"107","author":"Spencer","year":"2012","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"B34","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.diagmicrobio.2015.06.021S0732-8893(15)00225-4","article-title":"Alterations to antigen-specific immune responses before and after multidrug therapy of leprosy","volume":"83","author":"Freitas","year":"2015","journal-title":"Diagn Microbiol Infect Dis"},{"key":"B35","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1590\/S0074-02762012000900013","article-title":"Brazilian clinical trial of uniform multidrug therapy for leprosy patients: the correlation between clinical disease types and adverse effects","volume":"107","author":"Gon\u00e7alves","year":"2012","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"B36","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1590\/S0074-02762012000900005","article-title":"A clinical trial for uniform multidrug therapy for leprosy patients in Brazil: rationale and design","volume":"107","author":"Penna","year":"2012","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"B37","doi-asserted-by":"crossref","first-page":"308","DOI":"10.47276\/lr.83.3.308","article-title":"Primary results of clinical trial for uniform multidrug therapy for leprosy patients in Brazil (U-MDT\/CT-BR): reactions frequency in multibacillary patients","volume":"83","author":"Penna","year":"2012","journal-title":"Lepr Rev"},{"key":"B38","doi-asserted-by":"crossref","first-page":"267","DOI":"10.47276\/lr.85.4.267","article-title":"Patient profile and treatment satisfaction of Brazilian leprosy patients in a clinical trial of uniform six-month multidrug therapy (U-MDT\/CT-BR)","volume":"85","author":"Ferreira","year":"2014","journal-title":"Lepr Rev"},{"key":"B39","doi-asserted-by":"crossref","first-page":"262","DOI":"10.47276\/lr.85.4.262","article-title":"Results from the clinical trial of uniform multidrug therapy for leprosy patients in Brazil (U-MDT\/CT-BR): decrease in bacteriological index","volume":"85","author":"Penna","year":"2014","journal-title":"Lepr Rev"},{"key":"B40","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s40249-016-0203-010.1186\/s40249-016-0203-0","article-title":"Can baseline ML flow test results predict leprosy reactions? An investigation in a cohort of patients enrolled in the uniform multidrug therapy clinical trial for leprosy patients in Brazil","volume":"5","author":"Hungria","year":"2016","journal-title":"Infect Dis Poverty"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e0005396","DOI":"10.1371\/journal.pntd.0005396","article-title":"Leprosy reactions: the predictive value of Mycobacterium leprae-specific serology evaluated in a Brazilian cohort of leprosy patients (U-MDT\/CT-BR)","volume":"11","author":"Hungria","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e0005598","DOI":"10.1371\/journal.pntd.0005598PNTD-D-17-00193","article-title":"Whole genome sequencing distinguishes between relapse and reinfection in recurrent leprosy cases","volume":"11","author":"Stefani","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e0005725","DOI":"10.1371\/journal.pntd.0005725PNTD-D-17-00069","article-title":"Uniform multidrug therapy for leprosy patients in Brazil (U-MDT\/CT-BR): results of an open label, randomized and controlled clinical trial, among multibacillary patients","volume":"11","author":"Penna","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"B44","volume-title":"Data Analysis Using Regression and Multilevel\/Hierarchical Models","author":"Gelman","year":"2007"},{"key":"B45","volume-title":"Data Analysis Using Stata","author":"Kohler","year":"2009"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1111\/j.1365-3156.2007.01951.x","article-title":"Utility of measuring serum levels of anti-PGL-I antibody, neopterin and C-reactive protein in monitoring leprosy patients during multi-drug treatment and reactions","volume":"12","author":"Silva","year":"2007","journal-title":"Trop Med Int Health"},{"key":"B47","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1590\/S0037-86822008000700005","article-title":"The result patterns of ML flow and ELISA (PGL-I) serologic tests in leprosy-endemic and non-endemic areas","volume":"41","author":"Silva","year":"2008","journal-title":"Rev Soc Bras Med Trop"},{"key":"B48","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12879-015-0962-410.1186\/s12879-015-0962-4","article-title":"Antigen-specific assessment of the immunological status of various groups in a leprosy endemic region","volume":"15","author":"Fabri","year":"2015","journal-title":"BMC Infect Dis"},{"key":"B49","doi-asserted-by":"publisher","first-page":"8868","DOI":"10.1038\/s41598-017-07803-710.1038\/s41598-017-07803-7","article-title":"Field-friendly serological tests for determination of M. leprae-specific antibodies","volume":"7","author":"van Hooij","year":"2017","journal-title":"Sci Rep"},{"key":"B50","first-page":"356","article-title":"Assessment of anti-PGL-I as a prognostic marker of leprosy reaction","volume":"66","author":"Stefani","year":"1998","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"B51","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1590\/0074-02760150198","article-title":"Multibacillary leprosy patients with high and persistent serum antibodies to leprosy IDRI diagnostic-1\/LID-1: higher susceptibility to develop type 2 reactions","volume":"110","author":"Mizoguti","year":"2015","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"B52","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1093\/trstmh\/trx0263867404","article-title":"Anti-natural octyl disaccharide-leprosy IDRI diagnostic (NDO-LID) antibodies as indicators of leprosy reactions and neuritis","volume":"111","author":"Serrano-Coll","year":"2017","journal-title":"Trans R Soc Trop Med Hyg"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00915\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T22:53:09Z","timestamp":1604271189000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00915\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,14]]},"references-count":52,"alternative-id":["10.3389\/fimmu.2018.00915"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.00915","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,14]]},"article-number":"915"}}